Please turn JavaScript on
header-image

China Med Device

Receive updates from China Med Device for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from China Med Device. Unsubscribe at any time.

Site title: China Medical Device - Accelerate Your Medical Device's Entry Into China

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.45 / week

Message History

Here’s the latest China NMPA regulatory and clinical affairs news for medical device and IVDs pros in January 2026. These updates are presented by China Med Device, LLC, your partner in Chinese market access. Policies China Expands Pre-Submission Technical Consultation for Device Registration: What Overseas Manufacturers Need to Know Starting January 1, 2026, NMPA will […]


Read full story

OCT-Guided Ocular Injections Intravitreal injections are a cornerstone of modern retinal therapy, used to deliver anti-VEGF agents for AMD, diabetic macular edema, and other retinal disorders. Although the procedure is generally safe, complications such as retinal injury, vitreous hemorrhage, or uneven drug distribution remain concerns. OCT guidance can enhance injection safe...


Read full story

Optical Coherence Tomography (OCT) has become an indispensable imaging tool in ophthalmology, offering high-resolution, non-invasive, real-time cross-sectional visualization of ocular tissues. Since its introduction in the early 1990s, OCT has rapidly evolved and expanded its clinical applications from retinal diagnostics to surgical guidance and therapeutic monitoring. In op...


Read full story

Accurate medical device classification is the foundation of regulatory compliance, registration strategy, clinical planning, and market access in China. NMPA Classification Catalog was published in August 2017. After the release, several modifications have been made and many classification results have been issued reflect the latest technology and regulatory changes. China Me...


Read full story

Starting January 1, 2026, NMPA will further expand its pre-submission technical consultation program for medical device registration. In addition to the National Center, three regional branches—Beijing-Tianjin-Hebei, Central China, and Southwest China—will provide structured pre-acceptance technical consultations, joining the already established Yangtze River Delta and Greate...


Read full story